Avondale Cuts MedAssets (MDAS) to Market Perform

Article Stock Quotes (1) Comments (0)

Avondale Partners just downgraded MedAssets (NASDAQ: MDAS) from Market Outperform to Market Perform amid the company's Q4 miss last night.

A wave of downgrades is hitting the stock today, with at least six additional research firms also downgrading the stock this morning.

Shares of MDAS last traded at $14.99, down 29.6% from yesterday's closing price.

For more ratings news on MedAssets click here and for the rating history of MedAssets click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
• William Blair Downgrades Savient Pharmaceuticals (SVNT) to Market Perform
• Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'

Create E-mail Alert Related Categories

Downgrades

Related Entities

Avondale Partners, Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?